News Highlights

January 30, 2012
Concert Pharmaceuticals to Present at Epilepsy Pipeline Update Conference

January 18, 2012
New Patents Expand Concert Pharmaceuticals’ Patent Estate of Deuterium-Based Therapeutics; 25 Patents Issued Worldwide

November 15, 2011
Concert Pharmaceuticals Announces NIH Research Collaboration for Rare and Neglected Diseases

November 14, 2011
Concert Presents Phase 1 Data for CTP-499 at ASN Kidney Week Meeting; Supports Advancement into Phase 2 in Diabetic Nephropathy Patients

more...

Welcome to Concert

Concert uses deuterium-based chemistry to create and develop highly differentiated new medicines by leveraging decades of pharmaceutical and clinical experience to reduce time, risk and expense.

Concert in the news... a selection of news stories featuring Concert.

Healthcare Global Magazine Concert Pharmaceuticals Changes the Industry with Deuterium

Upcoming Events

Concert will present at Cowen & Company 32nd Annual Health Care Conference on March 6, 2012 at 11:30 a.m. in Boston

Business Development/Strategic Partnering

Concert business development will present at BioNetwork East 2012, March 5-7, 2012 in Miami, FL